Richard K. Desser

1.5k citations
30 papers · 995 indexed · h-index 19
Topics
Lung Cancer Research Studies (8 papers)Breast Cancer Treatment Studies (7 papers)Lung Cancer Diagnosis and Treatment (6 papers)
Partner nations
United States

In The Last Decade

Richard K. Desser

29 papers receiving 878 citations

Peers

Richard K. Desser
Comparison fields: 5 of 95
  • Oncology 428
  • Pulmonary and Respiratory Medicine 354
  • Pathology and Forensic Medicine 218
  • Surgery 167
  • Cancer Research 141
Replace N. I. Nissen with:
N. I. Nissen Denmark
U. Fabry Germany
E H Cooper United Kingdom
D C Carter United Kingdom
Joel B. Levine United States
Hayakazu Nakazawa Japan
Robert H. Yonemoto United States
M. Bonnay France
C.G. Alexopoulos Greece
Kenneth B. Olson United States
Richard K. Desser relative to N. I. Nissen Denmark N. I. Nissen's profile →
Citations per field
00.5×4.7×
N. I. Nissen · 1×
Citations per year

Countries citing papers authored by Richard K. Desser

Since Specialization
Citations

This map shows the geographic impact of Richard K. Desser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard K. Desser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard K. Desser more than expected).

Fields of papers citing papers by Richard K. Desser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard K. Desser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard K. Desser. The network helps show where Richard K. Desser may publish in the future.

Co-authorship network of co-authors of Richard K. Desser

This figure shows the co-authorship network connecting the top 25 collaborators of Richard K. Desser. A scholar is included among the top collaborators of Richard K. Desser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard K. Desser. Richard K. Desser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 16
2 88
3 17
4 13
5 33
6 19
7
Treatment of soft tissue sarcoma with fibroblast interferon (beta-interferon): an American Cancer Society/Illinois Cancer Council Study.
5
8 21
9 6
10 23
11 39
12
Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).
61
13 29
14 13
15
Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
29
16
Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.
13
17 1
18 0
19 30
20 77

About Richard K. Desser

Richard K. Desser is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 995 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (8 papers), Breast Cancer Treatment Studies (7 papers) and Lung Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (428 citations), Pathology and Forensic Medicine (218 citations) and Pulmonary and Respiratory Medicine (354 citations). Richard K. Desser has collaborated with scholars based in United States. Frequent co-authors include Jacob D. Bitran, John E. Ultmann, Daniel Deykin, Mark Kozloff, Charles M. Shapiro, Harvey M. Golomb, S. Himmelhoch, Warren H. Evans, Michael G. Mage and Emma Shelton. Their work appears in journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026